BioSimilar Biotechnology Investors Beware? Thomas Sullivan May 9, 2017 0 One thing the pharmaceutical stock industry has seen over many decades is price sensitivity to small statements and comments made…
Affordable Care Act The ACHA Passes the House Thomas Sullivan May 8, 2017 0 On Thursday, May 5, 2017, House Republicans finally got what they have been asking for, and campaigning on, for several years.…
Anti Kickback Novo Nordisk Settles Qui Tam Suit Thomas Sullivan May 5, 2017 0 Novo Nordisk is in the midst of settling a whistleblower lawsuit that alleges that the company ran a “white-coat marketing scheme”…
False Claims Act Genentech Beats FCA Suit, Thanks to Escobar Thomas Sullivan May 4, 2017 0 On Monday, May 1, 2017, the United States Court of Appeals for the Third Circuit stopped a False Claims Act suit that accused…
DOJ Mylan Settlement Classified as “Too Low” Thomas Sullivan May 3, 2017 0 Many of our readers may remember back in October 2016, when Mylan agreed to pay $465 million to settle claims related to the way…
Drug Prices New Analysis Shows Out-of-Pocket Spending Based on List Price Thomas Sullivan May 2, 2017 0 New analysis from Amundsen Consulting, a division of QuintilesIMS, shows that more than half of commercially insured patients’…
Drug Prices Drug Shortages, Pricing, and Regulatory Activity Thomas Sullivan May 1, 2017 0 In a paper titled Drug Shortages, Pricing, and Regulatory Activity, Christopher Stromberg of Bates White Economic Consulting…
Congress CHRONIC Care Act Reintroduced in the Senate Thomas Sullivan Apr 28, 2017 0 On April 6, 2017, the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 was…
Events ExL Events to Host the 8th Aggregate Spend and Sunshine Act Conference Thomas Sullivan Apr 28, 2017 0 Unlock the Value of Transparent and Efficient Data Reporting to Improve the Operation of Your Organization ExL Events will host…
Congress Senate HELP Hearing on FDA User Fee Thomas Sullivan Apr 27, 2017 0 On March 21, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a hearing on Food and Drug Administration…